Home › Trial NCT00570908
Brain Mets - Capecitabine Plus Sunitinib and WBRT
- Trial IDNCT00570908
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorBaylor Breast Care Center
- Enrollment12
- Start date2009-02
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.